The revolutionary advancements in genetics and genomics has engendered considerable interest in treating complex genetic diseases such as cancer. The growth in this area has led to the emergence of viral and nonviral approaches that hold significant promise in providing clinical benefit to patients. Given the complexity of cancer, there are a variety of considerations that must be addressed when developing a gene therapy, which include:
- Choice of modality
- Mechanism of action
- Safety and efficacy studies needed to bring the therapy to clinical trials
This informative webinar explores some of the more common gene therapy approaches used in treating cancer, as well as discusses the development and regulatory path required to bring these modalities to patients.
Manu Kohli, PhD
Principal Scientific Advisor
Michael V. Templin, PhD
Director, Scientific Advisory Services
We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.